Antagonistic regulation of α-actinin alternative splicing by CELF proteins and polypyrimidine tract binding protein

  1. NATALIA GROMAK1,
  2. ARIANNE J. MATLIN1,
  3. THOMAS A. COOPER2, and
  4. CHRISTOPHER W.J. SMITH1
  1. 1Department of Biochemistry, University of Cambridge, Cambridge CB2 1GA, UK
  2. 2Departments of Pathology and Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA

Abstract

The α-actinin gene has a pair of alternatively spliced exons. The smooth muscle (SM) exon is repressed in most cell types by polypyrimidine tract binding protein (PTB). CELF (CUG-BP and ETR3-like factors) family proteins, splicing regulators whose activities are altered in myotonic dystrophy, were found to coordinately regulate selection of the two α-actinin exons. CUG-BP and ETR3 activated the SM exon, and along with CELF4 they were also able to repress splicing of the NM (nonmuscle) exon both in vivo and in vitro. Activation of SM exon splicing was associated with displacement of PTB from the polypyrimidine tract by binding of CUG-BP at adjacent sites. Our data provides direct evidence for the activity of CELF proteins as both activators and repressors of splicing within a single-model system of alternative splicing, and suggests a model whereby α-actinin alternative splicing is regulated by synergistic and antagonistic interactions between members of the CELF and PTB families.

Keywords

Footnotes

| Table of Contents